Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Follow-up of patients with severe asthma by noninvasive parameters of airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 52s Year: 2001
The clinical importance of small airway involvement in patients with asthma and COPD Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019
Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002
Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017
Clinical characteristics of asthma patients with small airway dysfunction Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020
Smoking and airway inflammation in asymptomatic subjects and in patients with chronic airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 90s Year: 2002
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007
On relationship between local and systemic chronic inflammation and between level of hypoxia and bronchial obstruction in COPD pts Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Current control, airway inflammation, and subsequent exacerbation in patients with asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies? Source: Eur Respir J 2006; 27: 248-249 Year: 2006
Clinical parameters predict the risk of acute exacerbation of COPD better than bronchial obstruction degree Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001
The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013
NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021 Year: 2021
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011
The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015
Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives Source: Eur Respir Rev 2015; 24: 594-601 Year: 2015